Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus propofol for postoperative sleep quality after cardiac surgery
IRCT20161127031131N3Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronary arteriosclerosis comparing Dexmedetomidine group with Propofol group (2 arms). Primary endpoint: Sleep quality. Started May 2021; status: completed.
02
Drugs
dexmedetomidinepropofol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20161127031131N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20161127031131N3.